Phytohemagglutinin

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: immunity inflammation digestion

Research Overview

Phytohemagglutinin (PHA) is most extensively studied as (i) a plant lectin with immunostimulatory and immunomodulatory activity, and (ii) a standardized experimental tool to provoke immune activation in vitro and in vivo. Across the abstracts, PHA is repeatedly used to stimulate lymphocyte proliferation (e.g., peripheral blood mononuclear cells) and to elicit measurable inflammatory or immune responses such as skin swelling in birds and cutaneous basophil hypersensitivity in poultry. It is also examined within broader lectin research that considers potential gastrointestinal and immune risks of dietary lectins, and it appears in applied biomedical contexts as a trigger to test anti-inflammatory interventions (e.g., plant extracts) or immunoregulatory biologics (e.g., stem cell secretome/exosomes). A smaller but notable area is oncology, where PHA is investigated as a potential chemotherapy adjuvant to increase tumor cell sensitivity to agents such as cisplatin and adriamycin.

The strongest evidence supported by these abstracts is that PHA reliably induces immune activation that is quantifiable and experimentally useful: it drives lymphocyte proliferation in culture and provokes reproducible inflammatory/immune readouts in animal models (e.g., swelling responses). This makes it a robust probe for assessing immunomodulatory effects of interventions, with examples including amniotic fluid stem cell–derived exosomes reducing PHA-driven lymphocyte proliferation (while non-exosomal conditioned media promoted lymphocyte apoptosis) and tucumã (Astrocaryum aculeatum) extract attenuating PHA-associated inflammatory and oxidative stress markers in macrophage cultures. Evidence also supports PHA’s relevance to translational questions—e.g., as a functional readout for immune suppression or modulation—though in the provided abstracts this is primarily demonstrated in controlled experimental settings rather than definitive clinical outcomes.

Key gaps include limited clarity on dose–response relationships, mechanisms, and context dependence of PHA’s effects (beneficial immunomodulation versus pro-inflammatory or autoimmune-relevant activity), particularly as highlighted in the broader dietary lectin review. More research is needed to connect PHA-induced assays to clinically meaningful endpoints, to standardize protocols across models (cell type, stimulation conditions, and readouts), and to disentangle effects attributable to PHA itself versus downstream mediators in complex systems (e.g., whole secretomes). In oncology, the adjuvant findings warrant deeper mechanistic work (uptake, signaling, drug transport/resistance pathways) and validation in in vivo models and safety-focused studies, given lectins’ potential toxicity and immunogenicity. Overall, PHA is well established as an immunological stimulant and research tool, while its therapeutic positioning (as an adjuvant or immunomodulator) remains comparatively early-stage and requires rigorous translational validation.

1. What conditions has Phytohemagglutinin been studied for?

  • Immune activation/inflammation models (research tool): Multiple abstracts use phytohemagglutinin (PHA) to stimulate immune cells (e.g., peripheral blood mononuclear cells, splenocytes, macrophage-like cells) to model inflammation or T-cell activation.

  • Diarrhea and intestinal injury/dysbiosis (animal model): A rat model of PHA-induced diarrhea with dysbiosis (notably E. coli hyperproliferation) and shortened jejunal villi.

  • Cancer (cell culture): Lung cancer cell studies testing PHA as a chemotherapy adjuvant with cisplatin (DDP) and adriamycin (ADM), including a multidrug-resistant strain (A549-R).

  • Autoimmunity/inflammatory disease context (indirect): A review abstract notes that some lectins, including PHA, have been associated with inflammatory responses and autoimmune disorders (broad statement; not a specific clinical trial).

  • Immune function readouts in animals (biomarker/assay): PHA-induced skin swelling is used as an in vivo immune responsiveness test in house sparrows and lizards; broiler studies used a PHA skin test to assess immune response to dietary interventions.

  • Rheumatoid arthritis mechanism work (ex vivo): In collagen-induced arthritis models, splenocytes were stimulated with PHA to test whether koumine inhibits T-cell activation (PHA used as a stimulus, not a treatment).

2. Does it work in treating those conditions? Summarize the evidence.

  • As a treatment for diarrhea/inflammation: The abstracts do not present PHA as a therapy for diarrhea; rather, PHA induces diarrhea and dysbiosis in rats. Improvement came from the probiotic Bifidobacterium bifidum G9-1 (BBG9-1), which improved dysbiosis, diarrhea symptoms, and jejunal villus length in the PHA-induced model.

  • As an anti-cancer/chemo-adjuvant: In lung cancer cell experiments, PHA enhanced sensitivity to cisplatin (DDP) and adriamycin (ADM). Mechanistically, the abstract reports that PHA + DDP/ADM inhibited autophagy and promoted apoptosis, and that PHA changed the cell membrane to increase intracellular chemotherapy drug concentration, including increasing ADM concentration in multidrug-resistant A549-R cells. This is in vitro evidence only (no animal or human outcomes reported in the provided abstracts).

  • As an immunomodulatory therapy: The stem-cell exosome abstract used PHA to stimulate PBMCs and then tested amniotic fluid stem cell (AFSC) secretome components. AFSC-derived exosomes decreased lymphocyte proliferation under PHA stimulation, while conditioned medium without exosomes mainly induced lymphocyte apoptosis. This supports PHA’s role as a stimulus to reveal immunomodulatory effects of other interventions, not PHA as a treatment.

  • Bottom line: In these abstracts, PHA is primarily a laboratory tool to provoke immune activation or pathology (e.g., diarrhea), with one line of cell-culture evidence suggesting potential as a chemotherapy adjuvant. There is no clinical evidence in the provided abstracts demonstrating that PHA treats a disease in humans.

3. What health benefits does it have?

  • Potential anti-tumor adjuvant effect (preclinical): In lung cancer cell lines, PHA increased the cytotoxic effect of cisplatin and adriamycin and appeared to help overcome multidrug resistance by increasing intracellular drug concentration and shifting cells toward apoptosis (with reported inhibition of autophagy).

  • Research/diagnostic utility (not a direct “health benefit”): Several abstracts demonstrate PHA’s value as a standardized immune stimulant to measure immune competence or immunomodulation (e.g., PHA-induced skin swelling in birds/lizards; PHA-stimulated PBMC proliferation assays).

  • Important limitation: The provided abstracts do not show clear, direct human health benefits from ingesting or supplementing PHA. Much of the evidence is mechanistic, assay-based, or cell culture.

4. Does it have any downsides or side effects?

  • Pro-inflammatory/autoimmune concern (review-level statement): The dietary lectin review notes that some lectins, including PHA, have been associated with inflammatory responses and autoimmune disorders. This is a broad association in a review context; the abstract does not provide dose, route, or specific clinical outcomes.

  • Gastrointestinal harm in an animal model: In rats, PHA administration caused diarrhea, dysbiosis characterized by E. coli hyperproliferation, and shortened jejunal villus length (intestinal injury). This indicates potential for adverse GI effects when PHA is administered in a way that produces this model.

  • Immune activation effects (context-dependent): Because PHA is used to induce lymphocyte proliferation and inflammatory responses in vitro and in vivo assays, it can be considered an immune stimulant under experimental conditions—an effect that could be undesirable in inflammatory or autoimmune-prone contexts (consistent with the review’s caution).

  • Evidence gaps: The abstracts provided do not quantify side-effect rates in humans, do not establish safe supplemental dosing, and often involve experimental administration rather than typical dietary exposure.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings for phytohemagglutinin (no genotype-stratified responses, no variant-specific toxicity/efficacy, and no metabolism/transport polymorphism analyses).

  • No direct evidence in the abstracts linking PHA effects to specific genetic variants.

  • Related but not applicable: One abstract discusses tacrolimus functional immune testing; it is not about PHA pharmacogenomics and does not provide PHA-related genetic response data.

References

  1. From inflammation to immune regulation: The dual nature of dietary lectins in health and disease.
    Emadeldin H E Konozy, Makarim Elfadil M Osman (2024) - Heliyon
  2. Amniotic fluid stem cell exosomes: Therapeutic perspective.
    Francesca Beretti, Manuela Zavatti, Francesca Casciaro, Giuseppina Comitini, Fabrizia Franchi, Veronica Barbieri, Giovanni B La Sala, Tullia Maraldi (2018) - BioFactors (Oxford, England)
  3. House sparrows mitigate growth effects of post-natal glucocorticoid exposure at the expense of longevity.
    Jacquelyn K Grace, Louise Froud, Alizée Meillère, Frédéric Angelier (2017) - General and comparative endocrinology
  4. Astrocaryum aculeatum fruit improves inflammation and redox balance in phytohemagglutinin-stimulated macrophages.
    Fernanda L Cabral, Viviane M Bernardes, Daniela F Passos, Juliana S de Oliveira, Pedro H Doleski, Karine L Silveira, Mauren C Horvarth, João M Bremm, Fernanda Barbisan, Verônica F Azzolin, Cibele F Teixeira, Cinthia M de Andrade, Ivana B M da Cruz, Euler E Ribeiro, Daniela B R Leal (2020) - Journal of ethnopharmacology
  5. Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?
    Aliede E In 't Veld, Hendrika W Grievink, Mahdi Saghari, Frederik E Stuurman, Marieke L de Kam, Aiko P J de Vries, Brenda C M de Winter, Jacobus Burggraaf, Adam F Cohen, Matthijs Moerland (2019) - International journal of molecular sciences
  6. Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients.
    Juliana Ruiz Fernandes, Cibele Cristine Berto Marques da Silva, Aline Grandi da Silva, Regina Maria de Carvalho Pinto, Alberto José da Silva Duarte, Celso Ricardo Carvalho, Gil Benard (2018) - Lung
  7. Immune Responses in Broiler Chicks Fed Propolis Extraction Residue-supplemented Diets.
    C Eyng, A E Murakami, T C Santos, T G V Silveira, R B Pedroso, D A L Lourenço (2015) - Asian-Australasian journal of animal sciences
  8. Phytohemagglutinin from Phaseolus vulgaris enhances the lung cancer cell chemotherapy sensitivity by changing cell membrane permeability.
    Peipei Wang, Shitong Min, Congliang Chen, Junmei Hu, Dapeng Wei, Xia Wang (2024) - Journal of natural medicines
  9. Regulation effect of koumine on T-helper cell polarization in rheumatoid arthritis.
    Jian Yang, Ya-Rong Lin, Bo-Jun Xiong, Ze-Hong Chen, Yu-Fei Luo, Ying Xu, Yan-Ping Su, Hui-Hui Huang, Chang-Xi Yu (2022) - European journal of pharmacology
  10. Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.
    Yutaka Makizaki, Ayako Maeda, Yosuke Oikawa, Saya Tamura, Yoshiki Tanaka, Shunji Nakajima, Hiroshi Ohno, Hideki Yamamura (2019) - Microbiology and immunology
  11. Decrease in preferred temperature in response to an immune challenge in lizards from cold environments in Patagonia, Argentina.
    Fernando Duran, Jorgelina M Boretto, Nora R Ibargüengoytía (2020) - Journal of thermal biology
  12. Emotional Freedom Technique (EFT) Effects on Psychoimmunological Factors of Chemically Pulmonary Injured Veterans.
    Abdolreza Babamahmoodi, Zahra Arefnasab, Ahmad Ali Noorbala, Mostafa Ghanei, Farhang Babamahmoodie, Ahmad Alipour, Mohammad Hossein Alimohammadian, Farhad Riazi Rad, Vahid Khaze, Haideh Darabi (2015) - Iranian journal of allergy, asthma, and immunology
  13. Recombinant Phaseolus vulgaris phytohemagglutinin L-form expressed in the Bacillus brevis exerts in vitro and in vivo anti-tumor activity through potentiation of apoptosis and immunomodulation.
    Peipei Wang, Junmei Hu, Shitong Min, Congliang Chen, Yue Zhu, Yan Pan, Dapeng Wei, Xia Wang (2023) - International immunopharmacology
  14. High dose antigen treatment with a peptide epitope of myelin basic protein modulates T cells in multiple sclerosis patients.
    Eric W Loo, Mark J Krantz, Babita Agrawal (2012) - Cellular immunology
  15. Redirection of transfusion waste and by-products for xeno-free research applications.
    Vanessa Zammit, Mark Farrugia, Byron Baron (2020) - Journal of clinical and translational research
  16. Profiles of MicroRNAs in Interleukin-27-Induced HIV-Resistant T Cells: Identification of a Novel Antiviral MicroRNA.
    Suranjana Goswami, Xiaojun Hu, Qian Chen, Ju Qiu, Jun Yang, Deepak Poudyal, Brad T Sherman, Weizhong Chang, Tomozumi Imamichi (2021) - Journal of acquired immune deficiency syndromes (1999)
  17. No effect of carotenoid supplementation on phytohemagglutinin response or body condition of nestling house wrens.
    Jennifer L Sutherland, Charles F Thompson, Scott K Sakaluk (2012) - Physiological and biochemical zoology : PBZ
  18. Phytohemagglutinin ameliorates HFD-induced obesity by increasing energy expenditure.
    Yunxia Zhang, Jin Li, Hui-Hui Wang, Jiao Li, Yue Yu, Bo Li, Li Huang, Changjing Wu, Xiaomeng Liu (2021) - Journal of molecular endocrinology
  19. HLA-A2 Promotes the Therapeutic Effect of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Hyperoxic Lung Injury.
    Jihye Kwak, Wankyu Choi, Yunkyung Bae, Miyeon Kim, Soojin Choi, Wonil Oh, Hyejin Jin (2022) - Bioengineering (Basel, Switzerland)
  20. [Effect of phytohemagglutinin (PHA) from Yunnan white kidney bean on development of mouse embryos].
    Lifen Zhang, Changmei Wang, Mingjie Yang, Tian Zhang, Minkang Wang (2011) - Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!